A single nucleotide polymorphism of CYP2B6 found in Japanese enhances catalytic activity by autoactivation

被引:113
作者
Ariyoshi, N
Miyazaki, M
Toide, K
Sawamura, Y
Kamataki, T
机构
[1] Hokkaido Univ, Grad Sch Pharmaceut Sci, Lab Drug Metab, Kita Ku, Sapporo, Hokkaido 0600812, Japan
[2] Maruyama Clin, Sapporo, Hokkaido 0640820, Japan
关键词
cytochrome P450; genetic polymorphism; allosteric effect; homotropic cooperativity; autoactivation;
D O I
10.1006/bbrc.2001.4524
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A single nucleotide polymorphism (SNP) resulting in a substitution from Gin to His was found in exon 4 of the CYP2B6 gene in Japanese. The frequency of the variant allele was found to be 19.9%. The mutant- and the wild-type enzymes were expressed in Escherichia coli, and the effects of the single amino acid substitution on the catalytic activity were examined by investigating the kinetic profiles of 7-ethoxycoumarin O-deethylase activity. The wild-type enzyme showed typical Michaelis-Menten kinetics, while the mutant-type enzyme represented the sigmoidal kinetics with a higher V-max value compared to that of the wild-type enzyme. Eadie-Hofstee plots further revealed an existence of allosteric effects for the reaction catalyzed by the variant. This is the first evidence demonstrating that only one amino acid substitution, Gln172His, caused by natural SNP enhances the catalytic activity of CYP by obtaining the character of homotropic cooperativity. stool Academic Press.
引用
收藏
页码:1256 / 1260
页数:5
相关论文
共 28 条
[11]  
Faucette SR, 2000, DRUG METAB DISPOS, V28, P1222
[12]  
GOTOH O, 1992, J BIOL CHEM, V267, P83
[13]   Analysis of human cytochrome P450 3A4 cooperativity: Construction and characterization of a site-directed mutant that displays hyperbolic steroid hydroxylation kinetics [J].
Harlow, GR ;
Halpert, JR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (12) :6636-6641
[14]  
Heyn H, 1996, DRUG METAB DISPOS, V24, P948
[15]   Multiple forms of human p450 expressed in Saccharomyces cerevisiae [J].
Imaoka, S ;
Yamada, T ;
Hiroi, T ;
Hayashi, K ;
Sakaki, T ;
Yabusaki, Y ;
Funae, Y .
BIOCHEMICAL PHARMACOLOGY, 1996, 51 (08) :1041-1050
[16]   High catalytic activity of human cytochrome P450 co-expressed with human NADPH-cytochrome P450 reductase in Escherichia coli [J].
Iwata, H ;
Fujita, K ;
Kushida, H ;
Suzuki, A ;
Konno, Y ;
Nakamura, K ;
Fujino, A ;
Kamataki, T .
BIOCHEMICAL PHARMACOLOGY, 1998, 55 (08) :1315-1325
[17]   ESCHERICHIA-COLI EXPRESSION AND CHARACTERIZATION OF CYTOCHROMES P450 2B11, 2B1, AND 2B5 [J].
JOHN, GH ;
HASLER, JA ;
HE, YA ;
HALPERT, JR .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1994, 314 (02) :367-375
[18]  
Kobayashi K, 1999, DRUG METAB DISPOS, V27, P1429
[19]   Evaluation of atypical cytochrome P450 kinetics with two-substrate models: Evidence that multiple substrates can simultaneously bind to cytochrome P450 active sites [J].
Korzekwa, KR ;
Krishnamachary, N ;
Shou, M ;
Ogai, A ;
Parise, RA ;
Rettie, AE ;
Gonzalez, FJ ;
Tracy, TS .
BIOCHEMISTRY, 1998, 37 (12) :4137-4147
[20]   ALTERNATIVE SPLICING IN THE HUMAN CYTOCHROME P450IIB6 GENE GENERATES A HIGH-LEVEL OF ABERRANT MESSAGES [J].
MILES, JS ;
MCLAREN, AW ;
WOLF, CR .
NUCLEIC ACIDS RESEARCH, 1989, 17 (20) :8241-8255